Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.4744
-0.0045
(-0.94%)
As of 8:30:12 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-95,051
-168,882
-49,363
-139,988
-74,696
Investing Cash Flow
-18,415
119,883
-152,716
-648
37,027
Financing Cash Flow
6,051
94,675
153,017
63,646
230,412
End Cash Position
79,346
175,039
129,363
178,425
255,415
Interest Paid Supplemental Data
3,502
3,380
2,463
429
234
Capital Expenditure
-518
-2,168
-2,197
-648
-473
Issuance of Capital Stock
5,780
93,539
150,893
43,087
227,026
Issuance of Debt
--
--
--
24,042
--
Repayment of Debt
-351
-412
-272
-5,701
-313
Free Cash Flow
-95,569
-171,050
-51,560
-140,636
-75,169
12/31/2020 - 5/29/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
S09.BE Sutro Biopharma Inc
1.4700
-2.65%
W2J.F Carisma Therapeutics, Inc.
0.3784
-4.01%
1VT.DU Viking Therapeutics Inc
27.44
-2.42%
S09.MU Sutro Biopharma Inc
1.5200
-3.18%
1VT.SG Viking Therapeutics Inc
27.36
-1.94%
W2J.SG CARISMA Therapeutics Inc
0.3846
-0.41%
S09.F Sutro Biopharma, Inc.
1.4700
-2.00%
CHGX.CN ChitogenX Inc.
0.0050
0.00%
CYCCP Cyclacel Pharmaceuticals, Inc.
7.06
+1.58%
BLRX.TA BioLineRx Ltd.
2.0000
-4.76%